Electrotransport delivery device
AssigneeAlza Corporation
InventorsLarry A. McNichols, John D. Badzinski, Ronald P. Haak
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlza Corporation
InventorsLarry A. McNichols, John D. Badzinski, Ronald P. Haak
Estimating the term…
An electrotransport delivery device (410) includes control circuitry for discontinuously delivering a beneficial agent (eg, a drug) through a body surface (eg, skin 400). For example, the device may be the type which is manually activated by the patient or other medical personnel to activate electrotransport drug delivery. Once electrotransport delivery has been activated, a timer (221) counts a transition interval, typically about one minute, during which the device is allowed to operate and the impedance of the body surface (400) is allowed to stabilize. Thereafter, the electrotransport current and voltage are then monitored and compared to predetermined limits. Allowing for the transition interval permits tighter tolerances in monitoring the applied current.
An electrically powered device for delivering an agent by electrotransport through a body surface of a patient, including:
Dependencies are inferred from the claim text.